Microvascular replantation of scalp and facial parts

Case series published in Surgical Technology International (1995)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board

Research article — evidence reviewArticle reference

Evidence: Research reportEnsayos clínicosKind GM et al. · Surgical technology international, 1995

Abstract

Replantation of fingers, hands, feet, and extremities has become a relatively common procedure. There are a number of reports of successful replants of facial parts. Since the feeding vessels are extremely small, these replants are most challenging. Venous outflow is the most common problem, and leeches and anticoagulants are commonly needed, resulting in considerable blood loss and transfusions. Nonetheless, the successful replantation of a facial part yields an aesthetic and functional result far superior to any other reconstructive option. We review our experience with 7 scalps, 4 ears, and 2 lips.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Resumen

Single-institution experience with 7 scalp, 4 ear and 2 lip microvascular replants. Venous outflow most common problem requiring leech therapy and anticoagulation, with consequent significant blood loss and transfusion needs.

Por qué esto importa para la hirudoterapia

This article reviews the authors' experience with replantation of 7 scalps, 4 ears, and 2 lips, noting that venous outflow is the most common problem because the feeding vessels are extremely small. The abstract states that 'leeches and anticoagulants are commonly needed, resulting in considerable blood loss and transfusions' together as part of the management of these challenging cases. This is relevant to hirudotherapy because the abstract explicitly identifies leeches as a commonly used adjunct in facial and scalp replantation. However, the note cannot attribute the blood loss and transfusion burden to leeches alone, as the abstract assigns this to both leeches and anticoagulants combined, and no specific leech therapy protocols, outcomes, or comparative data are provided.

Citación

Microvascular replantation of scalp and facial parts.

Kind GM et al. · Surgical technology international, 1995

DOI PubMed

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Clinical Evidence Clinical Applications Microsurgery Outcomes Surgery Anticoagulation Compounds Hemostasis Direct Thrombin Inhibitors Otolaryngology

Aviso legal — investigación y educación

La información en esta página se proporciona únicamente con fines educativos e informativos y no constituye asesoramiento médico, diagnóstico o recomendaciones de tratamiento. Los resúmenes de evidencia clínica reflejan la literatura publicada revisada por pares y no implican eficacia terapéutica fuera de los contextos autorizados por la FDA.

La autorización FDA 510(k) para sanguijuelas medicinales se limita a indicaciones específicas. Las aplicaciones en investigación y fuera de indicación se identifican como tales. Los profesionales deben consultar las directrices vigentes de la FDA, los protocolos institucionales y las normativas estatales aplicables antes del uso clínico.

ASH apoya la evaluación rigurosa basada en evidencia de todas las aplicaciones de hirudoterapia mediante ensayos clínicos controlados e investigación revisada por pares.

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026